Compile Data Set for Download or QSAR
Report error Found 211 Enz. Inhib. hit(s) with all data for entry = 13333
TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781688BDBM781688(3-(4-(4-(bis(3- fluorophenyl) methyl)piperazine- 1...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781687BDBM781687(3-(5-((4- (diphenylamino)piperidin-1- yl)methyl)-4...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781684BDBM781684(3-(5-(4-(bis(3- fluorophenyl) methyl)piperazine- 1...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781683BDBM781683(3-(5-((4- (diphenylamino)piperidin-1- yl)methyl)-1...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781682BDBM781682(3-(5-((4-benzhydryl-3,3- dimethylpiperazin-1- yl)m...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781695BDBM781695(3-(5-((4- (diphenylamino)piperidin-1- yl)methyl)-7...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781671BDBM781671(3-(5-((4-(2,7-dichloro-9H- fluoren-9-yl)piperazin-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781799BDBM781799(3-(5-((4-(bis(3- fluorophenyl)methyl)piperazin- 1-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781669BDBM781669(3-(5-((4-benzhydryl-1,4- diazepan-1-yl)methyl)-1- ...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781797BDBM781797(3-(5-((4-(bis(3- fluorophenyl)methyl)piperazin- 1-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781796BDBM781796(3-(5-((4-(bis(3- fluorophenyl)methyl)piperazin- 1-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781681BDBM781681(3-(5-((7-benzhydryl-2,7- diazaspiro[3.5]nonan-2- y...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781680BDBM781680(3-(5-(4-(bis(3- fluorophenyl) methyl)piperazine- 1...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781679BDBM781679(2-((2-(2,6-dioxopiperidin-3- yl)-1-oxoisoindolin-5...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781678BDBM781678(3-(5-((4-benzhydryl-2- (trifluoromethyl)piperazin-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781676BDBM781676(3-(4-(4-(bis(4- fluorophenyl) methyl)piperazine- 1...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781675BDBM781675(3-(5-((4-(9H-fluoren-9- yl)piperazin-1-yl)methyl)-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781719BDBM781719(3-(4-((4- (diphenylamino)piperidin-1- yl)methyl)-1...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781718BDBM781718(3-(1-oxo-5-((4- (phenyl(pyridin-3- yl)methyl)piper...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781601BDBM781601(3-(5-((4- benzhydrylpiperazin-1- yl)methyl)-4-fluo...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781728BDBM781728(3-(5-(4- (diphenylamino)piperidine-1- carbonyl)-1-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781726BDBM781726(3-(6-fluoro-1-oxo-5-((4- (phenyl(pyridin-3- yl)met...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781598BDBM781598(3-(5-(((1S,4S)-5-benzhydryl- 2,5- diazabicyclo[2.2...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781724BDBM781724(3-(5-(4-(9H-fluoren-9- yl)piperazine-1-carbonyl)-1...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781595BDBM781595(3-(5-((4-(di(pyridin-3- yl)methyl)piperazin-1- yl)...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781722BDBM781722(3-(4-fluoro-1-oxo-5-((4- (phenyl(pyridin-3- yl)met...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781594BDBM781594(3-(5-(((1S,4S)-5-benzhydryl- 2,5- diazabicyclo[2.2...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781703BDBM781703(3-(4-fluoro-1-oxo-5-((4- (phenyl(pyridin-2- yl)ami...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781700BDBM781700(3-(5-(4-(bis(2- fluorophenyl) methyl)piperazine- 1...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781699BDBM781699(3-(1-oxo-5-((4- (phenyl(pyridin-2- yl)amino)piperi...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781707BDBM781707(3-(6-fluoro-1-oxo-5-((4- (phenyl(pyridin-2- yl)ami...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781753BDBM781753(3-(5-((5- benzhydrylhexahydropyrrolo [3,4-c]pyrrol...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781625BDBM781625(3-(5-((1-benzhydrylpiperidin- 4-yl)methyl)-1- oxoi...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781751BDBM781751(3-(5-(3-benzhydryl-3,6- diazabicyclo[3.1.1]heptane...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781750BDBM781750(3-(7-fluoro-1-oxo-5-((4- (phenyl(pyridin-4- yl)met...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781622BDBM781622(3-(5-(((R)-4-benzhydryl-2- methylpiperazin-1- yl)m...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781620BDBM781620(3-(5-(4-benzhydryl-3,5- dimethylpiperazine-1- carb...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781632BDBM781632(3-(5-(5-benzhydryl-2,5- diazabicyclo[2.2.2]octane-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781759BDBM781759(3-(5-((1R,4R)-5-benzhydryl- 2,5- diazabicyclo[2.2....)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781758BDBM781758(3-(5-((4-(di(pyridin-2- yl)methyl)piperazin-1- yl)...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781630BDBM781630(3-(5-((4-benzhydryl-2,6- dimethylpiperazin-1- yl)m...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781757BDBM781757(3-(4-((5- benzhydrylhexahydropyrrolo [3,4-c]pyrrol...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781629BDBM781629(3-(5-((1-benzhydrylpiperidin- 4-yl)amino)-1-oxoiso...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781628BDBM781628(3-(5-(5-benzhydryl-2,5- diazabicyclo[2.2.2]octane-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781755BDBM781755(3-(5-((1R,4R)-5-benzhydryl- 2,5- diazabicyclo[2.2....)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781626BDBM781626(3-(5-((4-benzhydryl-2,6- dimethylpiperazin-1- yl)m...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781736BDBM781736(3-(1-oxo-5-(4- (phenyl(pyridin-2- yl)amino)piperid...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781735BDBM781735(3-(5-(7-benzhydryl-2,7- diazaspiro[3.5]nonane-2- c...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781607BDBM781607(3-(5-((4-(bis(4- fluorophenyl)methyl)piperazin- 1-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 781732BDBM781732(3-(5-(4- (diphenylamino)piperidine-1- carbonyl)-7-...)
Affinity DataIC50: 500nMAssay Description:The CEREBLON BINDING kits (specification: 10,000 tests; product number: Catalog #64BDCRBNPEH; CISBIO company) was used to determine the CRBN binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

Displayed 1 to 50 (of 211 total ) | Next | Last >>
Jump to: